COVID-19 is an ongoing viral pandemic that emerged from East Asia and quickly spread to the rest of the world. SARS-CoV-2 is the virus causing COVID-19. Acute respiratory distress syndrome (ARDS) is definitely one of the main clinically relevant consequences in patients with COVID-19. Starting from the earliest reports of the COVID-19 pandemic, two peculiar neurological manifestations (namely, hyposmia/anosmia and dysgeusia) were reported in a relevant proportion of patients infected by SARS-CoV-2. At present, the physiopathologic mechanisms accounting for the onset of these symptoms are not yet clarified. CXCL10 is a pro-inflammatory chemokine with a well-established role in the COVID-19-related cytokine storm and in subsequent development of ARDS. CXCL10 is also known to be involved in coronavirus-induced demyelination. On these bases, a role for CXCL10 as the common denominator between pulmonary and olfactory dysfunctions could be envisaged. The aim of the present report will be to hypothesize a role for CXCL10 in COVID-19 olfactory dysfunctions. Previous evidences supporting our hypothesis, with special emphasis to the role of CXCL10 in coronavirus-induced demyelination, the anatomical and physiological peculiarity of the olfactory system, and the available data supporting their link during COVID-19 infections, will be overviewed.
BaggioliniM. 1998. Chemokines and leukocyte traffic. Nature392(6676):565–8.
3.
BergmannCCLaneTEStohlmanSA. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol4(2):121–32.
4.
ChannappanavarRFehrARVijayRMackMZhaoJMeyerholzDK, and others. 2016. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe19(2):181–93.
5.
ChannappanavarRPerlmanS.2017. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol39(5):529–39.
6.
CharoIFRansohoffRM. 2006. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med354(6):610–21.
7.
CheeverFSDanielsJB. 1949. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J Exp Med90(3):181–210.
8.
ChengJZhaoYXuGZhangKJiaWSunY, and others. 2019. The S2 subunit of QX-type infectious bronchitis coronavirus spike protein is an essential determinant of neurotropism. Viruses11(10):972. doi:10.3390/v11100972
9.
ClarkECDodgeHW. 1955. Effect of anosmia on the appreciation of flavor. Neurology5(9):671–4.
10.
CoperchiniFChiovatoLCroceLMagriFRotondiM.2020. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev53:25–32. doi:10.1016/j.cytogfr.2020.05.003
11.
de CastroF. 2009. Wiring olfaction: the cellular and molecular mechanisms that guide the development of synaptic connections from the nose to the cortex. Front Neurosci3:52. doi:10.3389/neuro.22.004.2009
12.
DesforgesMLe CoupanecADubeauPBourgouinALajoieLDubéM, and others. 2019. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?Viruses12(1):14. doi:10.3390/v12010014
13.
DubéMLe CoupanecAWongAHMRiniJMDesforgesMTalbotPJ. 2018. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J Virol92(17): e00404–18 doi:10.1128/JVI.00404-18
14.
FaureEPoissyJGoffardAFournierCKipnisETitecatM, and others. 2014. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?PLoS One9(2):e88716.
15.
GaneSBKellyCHopkinsC.2020. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?Rhinology58(3):299–301.
16.
GuJGongEZhangBZhengJGaoZZhongY, and others. 2005. Multiple organ infection and the pathogenesis of SARS. J Exp Med202(3):415–24.
17.
GuanWJNiZYHuYLiangWHOuCQHeJX, and others. 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med41(5):629–33.
18.
HouYJOkudaKEdwardsCEMartinezDRAsakuraTDinnonKH, and others. 2020. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. Epub May 27. doi:10.1016/j.cell.2020.05.042
19.
IchikawaAKubaKMoritaMChidaSTezukaHHaraH, and others. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med187(1):65–77.
20.
KoyuncuOOHogueIBEnquistLW. 2013. Virus infections in the nervous system. Cell Host Microbe13(4):379–93.
21.
LaneTEBuchmeierMJ. 1997. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol5(1):9–14.
22.
LechienJRChiesa-EstombaCMPlaceSVan LaethemYCabarauxPMatQ, and others. 2020. Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. Epub Apr 30. doi:10.1111/joim.13089
23.
LiYCBaiWZHashikawaT. 2020a. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol92(6):552–5. doi:10.1002/jmv.25728
24.
LiGFanYLaiYHanTLiZZhouP, and others. 2020b. Coronavirus infections and immune responses. J Med Virol92(4):424–32.
25.
LibbeyJELaneTEFujinamiRS. 2014. Axonal pathology and demyelination in viral models of multiple sclerosis. Discov Med18(97):79–89.
26.
LiuMTKeirsteadHSLaneTE. 2001. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol167(7):4091–7.
27.
LuersJCRokohlACLoreckNWawer MatosPAAugustinMDewaldF, and others. 2020. Olfactory and gustatory dysfunction in coronavirus disease 19 (COVID-19). Clin Infect Dis. Epub May 1. doi:10.1093/cid/ciaa525
28.
LusterAD. 1998. Chemokines—chemotactic cytokines that mediate inflammation. N Engl J Med338(7):436–45.
29.
LusterADUnkelessJCRavetchJV. 1985. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature315(6021):672–6.
30.
MaoLJinHWangMHuYChenSHeQ, and others. 2020. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurole201127. doi:10.1001/jamaneurol.2020.1127
31.
MarroBSBlancCALoringJFCahalanMDLaneTE. 2014. Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies. Expert Rev Neurother14(10):1169–79.
32.
MartenNWStohlmanSABergmannCC. 2000. Role of viral persistence in retaining CD8(+) T cells within the central nervous system. J Virol74(17):7903–10.
33.
MuusC. 2020. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiV. https://doi.org/10.1101/2020.04.19.049254
34.
NanBGetchellMLPartinJVGetchellTV. 2001. Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation. J Comp Neurol435(1):60–77.
35.
NarumiSKaburakiTYoneyamaHIwamuraHKobayashiYMatsushimaK.2002. Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol32(6):1784–91.
36.
NathA. 2020. Neurologic complications of coronavirus infections. Neurology. 94(19):809–10. doi:10.1212/WNL.0000000000009455
37.
NetlandJMeyerholzDKMooreSCassellMPerlmanS.2008. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol82(15):7264–75.
38.
PanditLBanMBeechamAHMcCauleyJLSawcerSD’CunhaA, and others. 2016. European multiple sclerosis risk variants in the south Asian population. Mult Scler22(12):1536–40.
39.
ParraBHintonDRMartenNWBergmannCCLinMTYangCS, and others. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol162(3):1641–7.
40.
PeirisJSYuenKYOsterhausADStöhrK.2003. The severe acute respiratory syndrome. N Engl J Med349(25):2431–41.
41.
PolitiLSSalsanoEGrimaldiM.2020. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. Epub May 29. doi:10.1001/jamaneurol.2020.2125
42.
QuintJKDonaldsonGCGoldringJJBaghai-RavaryRHurstJRWedzichaJA. 2010. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Chest137(4):812–22.
43.
ReichardRRKashaniKBBoireNAConstantopoulosEGuoYLucchinettiCF. 2020. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol140(1):1–6. doi:10.1007/s00401-020-02166-2
44.
RotondiMChiovatoL.2011. The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. Curr Pharm Des17(29):3202–16.
45.
RotondiMLazzeriERomagnaniPSerioM.2003. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest26(2):177–80.
46.
SkinnerDMarroBSLaneTE. 2019. Chemokine CXCL10 and coronavirus-induced neurologic disease. Viral Immunol32(1):25–37.
47.
StilesLNHoskingMPEdwardsRAStrieterRMLaneTE. 2006. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol36(3):613–22.
48.
SuSWongGShiWLiuJLaiACKZhouJ, and others. 2016. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol24(6):490–502.
49.
SuzukiMSaitoKMinWPVladauCToidaKItohH, and others. 2007. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope117(2):272–7.
50.
TannenbaumCSTubbsRArmstrongDFinkeJHBukowskiRMHamiltonTA. 1998. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol161(2):927–32.
51.
TsaiLKHsiehSTChangYC. 2005. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan14(3):113–9.
52.
VairaLASalzanoGDeianaGDe RiuG.2020. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 130(7):1787. doi:10.1002/lary.28692
53.
VallièresLCampbellILGageFHSawchenkoPE. 2002. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci22(2):486–92.
54.
van RielDVerdijkRKuikenT. 2015. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol235(2):277–87.
55.
WangDHuBHuCZhuFLiuXZhangJ, and others. 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA323(11):1061–9. doi:10.1001/jama.2020.1585
56.
WuAWWalgamaESHigginsTSBorrelliMVardanyanNHoppS, and others. 2020. Eustachian tube quality of life and severity of disease in patients with chronic rhinosinusitis. Am J Rhinol Allergy34(4):532–6. doi:10.1177/1945892420912366
57.
WuGFDandekarAAPeweLPerlmanS.2000. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol165(4):2278–86.
58.
WölfelRCormanVMGuggemosWSeilmaierMZangeSMüllerMA, and others. 2020. Virological assessment of hospitalized patients with COVID-2019. Nature581(7809):465–9. doi:10.1038/s41586-020-2196-x
59.
XuGYangYDuYPengFHuPWangR, and others. 2020. Clinical pathway for early diagnosis of COVID-19: updates from experience to evidence-based practice. Clin Rev Allergy Immunol. Epub Apr 24. doi:10.1007/s12016-020-08792-8
60.
YangYChenguangSJinxiuLJingYYangMWangF, and others. 2020. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. MerRxiv. https://doi.org/10.1101/2020.03.02.20029975
61.
ZhangCWuZLiJWZhaoHWangGQ. 2020. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents55(5):105954. doi:10.1016/j.ijantimicag.2020.105954
62.
ZhouJChuHLiCWongBHChengZSPoonVK, and others. 2014. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis209(9):1331–42.
63.
ZieglerCGKAllonSJNyquistSKMbanoIMMiaoVNTzouanasCN, and others. 2020. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell181(5):1016–1035.e19. doi:10.1016/j.cell.2020.04.035
